Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

34.31
-5.1100-12.96%
Pre-market: 34.790.4800+1.40%05:02 EDT
Volume:273.91K
Turnover:9.80M
Market Cap:42.49M
PE:- -
High:39.76
Open:39.48
Low:33.75
Close:39.42
52wk High:152.22
52wk Low:11.52
Shares:1.24M
Float Shares:1.24M
Volume Ratio:1.30
T/O Rate:22.12%
Dividend:3.85
Dividend Rate:11.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Personalis Acquisition Price Warranted by Growth Prospects, Needham Says

MT Newswires Live
·
Jul 21

Morgan Stanley sees strategic logic in Personalis deal despite financial hurdles

TIPRANKS
·
Jul 21

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

TIPRANKS
·
Jul 21

Top Midday Decliners

MT Newswires Live
·
Jul 21

Tempus AI Price Target Maintained with a $75.00/share by Needham

Dow Jones
·
Jul 21

Midday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis

TIPRANKS
·
Jul 21

Personalis downgraded to Hold from Buy at Needham

TIPRANKS
·
Jul 20

AI Software Shares Fall. Tempus AI Sinks 9%; ServiceNow Down over 4%; Braze, SoundHound AI, Docusign, BigBear.ai Down over 2%

Tiger Newspress
·
Jul 20

Personalis to be acquired by Tempus AI in merger

TIPRANKS
·
Jul 20

Tempus AI Shares Down 6.4%

THOMSON REUTERS
·
Jul 20

Tempus Publishes Investor Deck on Planned Personalis Acquisition to Expand MRD Testing Platform

Reuters
·
Jul 20

Sector Update: Healthcare

MT Newswires Live
·
Jul 20

Tempus AI Shares Fall 8.5% Premarket After Co to Acquire Personalis in $1.5 Bln Deal

THOMSON REUTERS
·
Jul 20

Tempus to Acquire Personalis for $1.5 Billion

Reuters
·
Jul 20

Tempus AI to acquire Personalis for $16.25 per share

TIPRANKS
·
Jul 20

Tempus AI Agrees to Buy Personalis for USD 16.25 Per Share in USD 1.5 Billion Deal

Reuters
·
Jul 20

Tempus AI Inc - Maximum Exchange Ratio Set at 0.3356 Tempus AI Shares Per Personalis Share

THOMSON REUTERS
·
Jul 20

Tempus - Consideration Structured as 100% Stock, Cash Option Capped at 50%

THOMSON REUTERS
·
Jul 20

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (mrd) into Its Ai-enabled Precision Oncology Platform

THOMSON REUTERS
·
Jul 20

Tempus AI Inc - Cash Consideration Will be Financed with Cash on Hand and Borrowings Under Company's Then Existing Credit Facilities

THOMSON REUTERS
·
Jul 20